FDA

Treatments for substance use disorders are rare or non-existent. The FDA hopes to change that

by
Treatments for substance use disorders are rare or non-existent. The FDA hopes to change that

When Amanda isn’t taking her attention deficit hyperactivity disorder (ADHD) medication, she struggles to function both mentally and physically. Depression, anxiety and chronic pain from fibromyalgia have all become more prominent for the 46-year-old, which has exacerbated her ADHD symptoms, making everyday tasks like bathing washing becomes a challenge. While she didn’t face any disruptions … Read more

The FDA approved Bimzelx to treat moderate to severe plaque psoriasis

by
Generic FDA News infographic

October 18, 2023 read 1 minute Add a subject to your email notifications Receive emails when new articles are posted Please provide your email address to receive an email when a new article is posted . ” data-action=”subscribe”> Subscribe We cannot process your request. Please try again later. If you continue … Read more

FDA approves Tenapanor for chronic kidney disease

by
FDA approves Tenapanor for chronic kidney disease

The FDA approved tenapanor (Xphozah; Ardelyx, Inc.), making it the first and only phosphate absorption inhibitor approved to reduce serum phosphorus in adults with chronic kidney disease (CKD). Hemodialysis as an adjunctive therapy in patients with chronic kidney disease (CKD). who do not respond to phosphate binders or who do not tolerate any dose of … Read more

FDA issues additional guidance on masks

by
FDA issues additional guidance on masks

This latest guidance, dated September 5, 2023, is the latest update on the agency’s evolving stance.[1] To understand the agency’s new changes, it’s important to know these two definitions: Face mask Masks, with or without face shields, cover the user’s nose and mouth and may or may not meet a fluid barrier level or filtration … Read more

Pharmacies compounding Semaglutide raises concerns

by
Pharmacies compounding Semaglutide raises concerns

The US Food and Drug Administration (FDA) recently warned two online suppliers to stop manufacturing unapproved versions of semaglutide (marketed as Ozempic for type 2 diabetes). 2; Wegovy for obesity) and tirzepatide (Mounjaro). With ongoing shortages of these two popular drugs, compounded versions have become popular. According to the FDA, compounding pharmacies are allowed to … Read more

Hyloris announces US FDA approval of Maxigesic® IV

by
Hyloris announces US FDA approval of Maxigesic® IV

Maxigesic IV, a strong non-opioid analgesic, is marketed in the US under the trade name Combogesic IV First US sales expected early 2024, generating $2.1 million milestone payout Lige, Belgium October 18, 2023 7am CET Regulated Information – Internal Information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharmaceutical company committed to addressing unmet … Read more

Arthritis drugs used by millions are ‘tainted’ by hidden ingredients

by
Arthritis drugs used by millions are 'tainted' by hidden ingredients

By Emily Joshu Health reporter for Dailymail.Com 14:17 October 11, 2023, updated 15:02 October 11, 2023 FDA discovered at least 22 arthritis drugs contain hidden ingredients These ingredients may interact with other medications or cause side effects READ MORE: Brushing teeth properly helps reduce the risk of arthritis later in life Arthritis drugs used by … Read more

New drug to treat IBD and ulcerative colitis approved by FDA: Amazing results

by
New drug to treat IBD and ulcerative colitis approved by FDA: Amazing results

Medicine Via Marc Lallanilla Published October 16, 2023, 4:24 pm ET A new drug to treat a type of inflammatory bowel disease (IBD) has been approved by the Food and Drug Administration. On Friday, the FDA approved Pfizers etrasimod, brand name Velsipity, to treat adults with a chronic digestive disorder called ulcerative colitis (UC). The … Read more